112 related articles for article (PubMed ID: 21154646)
1. A proposed anatomical explanation for perineural spread of breast adenocarcinoma to the brachial plexus.
Hébert-Blouin MN; Amrami KK; Loukas M; Spinner RJ
Clin Anat; 2011 Jan; 24(1):101-5. PubMed ID: 21154646
[No Abstract] [Full Text] [Related]
2. An unusual triple-negative breast carcinoma.
Shousha S; Peston D; Gojis O; Palmieri C
Histopathology; 2009 Sep; 55(3):364-6. PubMed ID: 19723156
[No Abstract] [Full Text] [Related]
3. Triple-negative breast cancers: unique clinical presentations and outcomes.
Billar JA; Dueck AC; Stucky CC; Gray RJ; Wasif N; Northfelt DW; McCullough AE; Pockaj BA
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():384-90. PubMed ID: 20853062
[TBL] [Abstract][Full Text] [Related]
4. HER2-positive breast cancer metastatic to intracranial meningioma: a case report.
McCormack M; Rosa CS; Murphy M; Fox SB
J Clin Pathol; 2013 Jul; 66(7):633-4. PubMed ID: 23436926
[No Abstract] [Full Text] [Related]
5. Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression.
Demir H; Turna H; Can G; Ilvan S
J BUON; 2010; 15(4):774-82. PubMed ID: 21229645
[TBL] [Abstract][Full Text] [Related]
6. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
Gong Y; Booser DJ; Sneige N
Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
[TBL] [Abstract][Full Text] [Related]
7. F-18 FDG PET-CT appearance of metastatic brachial plexopathy in a case of carcinoma of the breast.
Luthra K; Shah S; Purandare N; Medhi S; Rangarajan V; Samuel AM
Clin Nucl Med; 2006 Jul; 31(7):432-4. PubMed ID: 16785819
[No Abstract] [Full Text] [Related]
8. Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria.
Brunelli M; Manfrin E; Martignoni G; Miller K; Remo A; Reghellin D; Bersani S; Gobbo S; Eccher A; Chilosi M; Bonetti F
Am J Clin Pathol; 2009 May; 131(5):678-82. PubMed ID: 19369627
[TBL] [Abstract][Full Text] [Related]
9. Is breast tumor progression really linear?
Polyak K
Clin Cancer Res; 2008 Jan; 14(2):339-41. PubMed ID: 18223205
[No Abstract] [Full Text] [Related]
10. Ductal type signet ring cell carcinoma of breast with growth pattern of pure mucinous carcinoma.
Leung KM; Yeoh GP; Chan JK; Cheung PS; Chan KW
Pathology; 2011 Apr; 43(3):282-4. PubMed ID: 21436644
[No Abstract] [Full Text] [Related]
11. Perineural spread of malignant melanoma from the mandible to the brachial plexus: case report.
Restrepo CE; Spinner RJ; Howe BM; Jentoft ME; Markovic SN; Lachance DH
J Neurosurg; 2015 Apr; 122(4):784-90. PubMed ID: 25614946
[TBL] [Abstract][Full Text] [Related]
12. Intraductal spread of invasive breast carcinoma has a positive correlation with c-erb B-2 overexpression and vascular invasion.
Jing X; Kakudo K; Murakami M; Nakamura Y; Nakamura M; Yokoi T; Yang Q; Oura S; Sakurai T
Cancer; 1999 Aug; 86(3):439-48. PubMed ID: 10430252
[TBL] [Abstract][Full Text] [Related]
13. Metastatic brachial plexopathy from breast cancer detected by 18F-FDG PET/MRI.
Treglia G; Paone G; Ceriani L; Giovanella L
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):54-5. PubMed ID: 23938189
[No Abstract] [Full Text] [Related]
14. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
15. Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature.
Brunelli M; Manfrin E; Miller K; Eccher A; Gobbo S; Reghellin D; Chilosi M; Remo A; Martignoni G; Menestrina F; Bonetti F
J Cutan Pathol; 2009 Jun; 36(6):702-5. PubMed ID: 19515052
[TBL] [Abstract][Full Text] [Related]
16. HER-2 amplification in tubular carcinoma of the breast.
Oakley GJ; Tubbs RR; Crowe J; Sebek B; Budd GT; Patrick RJ; Procop GW
Am J Clin Pathol; 2006 Jul; 126(1):55-8. PubMed ID: 16753605
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral heterogeneity of her-2/neu in invasive mammary carcinomas using fluorescence in-situ hybridization and tissue microarray.
Shin SJ; Hyjek E; Early E; Knowles DM
Int J Surg Pathol; 2006 Oct; 14(4):279-84. PubMed ID: 17041191
[TBL] [Abstract][Full Text] [Related]
18. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma.
Faratian D; Munro A; Twelves C; Bartlett JM
Histopathology; 2009 Jan; 54(2):254-7. PubMed ID: 19207951
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine1248-phosphorylated HER2 expression and HER2 gene amplification in female invasive ductal carcinomas.
Taniyama K; Ishida K; Toda T; Motoshita J; Kuraoka K; Saito A; Tani Y; Uike T; Teramoto S; Koseki M
Breast Cancer; 2008; 15(3):231-40. PubMed ID: 18264744
[TBL] [Abstract][Full Text] [Related]
20. Perineural Spread of Melanoma to the Brachial Plexus: Identifying the Anatomic Pathway(s).
Marek T; Laughlin RS; Howe BM; Spinner RJ
World Neurosurg; 2018 Mar; 111():e921-e926. PubMed ID: 29325942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
